Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.

BACKGROUND:The randomized clinical trial, SafeBoosC II, examined the effect of monitoring of cerebral oxygenation by near-infrared spectroscopy combined with a guideline on treatment when cerebral oxygenation was out of the target range. Data on cerebral oxygenation was collected in both the interve...

Full description

Bibliographic Details
Main Authors: Anne M Plomgaard, Thomas Alderliesten, Topun Austin, Frank van Bel, Manon Benders, Olivier Claris, Eugene Dempsey, Monica Fumagalli, Christian Gluud, Cornelia Hagmann, Simon Hyttel-Sorensen, Petra Lemmers, Wim van Oeveren, Adelina Pellicer, Tue H Petersen, Gerhard Pichler, Per Winkel, Gorm Greisen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5362210?pdf=render

Internet

http://europepmc.org/articles/PMC5362210?pdf=render

Similar Items